The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | |||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | ||||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | FIGI | (to the nearest dollar) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| HILLEVAX INC | COM | 43157M102 | 771,313 | 372,615 | SH | SOLE | 372,615 | 0 | 0 | |||
| JASPER THERAPEUTICS INC | COM NEW | 471871202 | 19,861,250 | 928,964 | SH | SOLE | 928,964 | 0 | 0 | |||
| KEZAR LIFE SCIENCES INC | COM NEW | 49372L209 | 556,893 | 82,871 | SH | SOLE | 82,871 | 0 | 0 | |||
| KORRO BIO INC | COM | 500946108 | 14,012,996 | 368,085 | SH | SOLE | 368,085 | 0 | 0 | |||
| TOURMALINE BIO INC | COM | 89157D105 | 15,041,493 | 741,691 | SH | SOLE | 741,691 | 0 | 0 | |||
| VENTYX BIOSCIENCES INC | COM | 92332V107 | 902,773 | 412,225 | SH | SOLE | 412,225 | 0 | 0 | |||